Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

423
CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB VERSUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 CANDOR STUDY BY NUMBER OF PRIOR LINES OFTHERAPY AND PRIOR THERAPIES
H. Quacha, A. Nookab, O. Samoylovac, C.P. Vennerd, T. Facone, A. Spencerf, S.Z. Usmanig, K. Weiselh, M. Mateosi, K. Kimj, S. Grosickik, K. Suzukil, S. Delimpasim, M. Obrejan, A. Zahlten-Kumelin
a University of Melbourne, St. Vincent's Hospital, Melbourne, Australia
b Winship Cancer Institute, Emory University, Atlanta, United States
c Nizhniy Novgorod Region Clinical Hospital, Nizhny Novgorod, Russia
d Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada
e Hôpital Claude Huriez, Lille, France
f Alfred Health-Monash University, Melbourne, Australia
g Atrium Health, Charlotte, United States
h University Medical Center Hamburg-Eppendorf, Hamburg, Germany
i University Hospital Salamanca/IBSAL, Salamanca, Spain
j Sungkyunkwan University, Samsung Medical Center, Seoul, Korea
k Silesian Medical University, Katowice, Poland
l Japanese Red Cross Medical Center, Tokyo, Japan
m General Hospital Evangelismos, Athens, Greece
n Amgen Inc., Thousand Oaks, United States
Ver más
Lido
3093
Vezes
que se leu este artigo
1324
Total PDF
1769
Total HTML
Compartilhar estatísticas
Informação do artigo
ISSN: 25311379
Idioma original: Inglês
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2025 6 26 5 31
2025 5 52 17 69
2025 4 45 14 59
2025 3 59 11 70
2025 2 54 19 73
2025 1 41 26 67
2024 12 34 17 51
2024 11 49 22 71
2024 10 40 16 56
2024 9 40 27 67
2024 8 41 37 78
2024 7 28 23 51
2024 6 23 21 44
2024 5 39 25 64
2024 4 26 27 53
2024 3 27 25 52
2024 2 22 20 42
2024 1 21 32 53
2023 12 19 19 38
2023 11 36 36 72
2023 10 22 38 60
2023 9 26 30 56
2023 8 14 17 31
2023 7 23 22 45
2023 6 24 14 38
2023 5 31 13 44
2023 4 20 7 27
2023 3 41 17 58
2023 2 16 14 30
2023 1 19 12 31
2022 12 31 15 46
2022 11 29 18 47
2022 10 33 36 69
2022 9 24 18 42
2022 8 25 14 39
2022 7 27 33 60
2022 6 21 20 41
2022 5 18 22 40
2022 4 19 28 47
2022 3 24 26 50
2022 2 23 19 42
2021 1 15 25 40
2021 12 25 21 46
2021 11 29 34 63
2021 10 34 32 66
2021 9 35 38 73
2021 8 27 34 61
2021 7 34 42 76
2021 6 47 36 83
2021 5 34 34 68
2021 4 136 65 201
2021 3 45 35 80
2021 2 21 13 34
2020 1 13 13 26
2020 12 22 17 39
2020 11 20 13 33
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Hematology, Transfusion and Cell Therapy